Jeffrey John Levine, DO
Hematology/Oncology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: 051589. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Levine’s office at (408) 851-1000 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$4,605,305
Pharmacies billed $4,605,305 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
253 generic and 300 brand-name prescriptions · $4,605,305 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tagrisso | 152 | $2,611,609 | $17,182 |
| Lorbrena | 18 | $418,062 | $23,226 |
| Mekinist | 23 | $356,070 | $15,481 |
| Tafinlar | 23 | $328,023 | $14,262 |
| Erivedge | 13 | $188,804 | $14,523 |
See all 14 drugs
| Tagrisso | 152 | $2,611,609 | $17,182 |
| Lorbrena | 18 | $418,062 | $23,226 |
| Mekinist | 23 | $356,070 | $15,481 |
| Tafinlar | 23 | $328,023 | $14,262 |
| Erivedge | 13 | $188,804 | $14,523 |
| Xalkori | 12 | $138,958 | $11,580 |
| Everolimus | 18 | $5,610 | $312 |
| Abiraterone Acetate | 19 | $5,264 | $277 |
| Gabapentin | 23 | $376 | $16 |
| Anastrozole | 13 | $367 | $28 |
| Dexamethasone | 11 | $320 | $29 |
| Albuterol Sulfate Hfa | 17 | $276 | $16 |
| Prednisone | 26 | $229 | $9 |
| Prochlorperazine Maleate | 13 | $188 | $14 |
Year by year
| 2024 | 553 | 103 | None | 54% | $4,605,305 |
| 2023 | 597 | 110 | 6% (38) | 40% | $3,536,433 |
| 2022 | 591 | 120 | 4% (25) | None | $3,684,692 |
| 2021 | 666 | 114 | 8% (50) | 47% | $3,983,673 |
| 2020 | 555 | 102 | 2% (13) | 50% | $3,147,810 |
| 2019 | 105 | 44 | None | 46% | $565,031 |
| 2018 | 19 | None | 0% (0) | None | $544 |
| 2017 | 20 | 11 | 0% (0) | None | $2,017 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Tagrisso | 112 | $1,874,356 | $16,735 |
| Tafinlar | 16 | $278,230 | $17,389 |
| Mekinist | 17 | $273,678 | $16,099 |
| Lorbrena | 11 | $240,183 | $21,835 |
| Lynparza | 12 | $192,983 | $16,082 |
| Xalkori | 12 | $150,108 | $12,509 |
| Abiraterone Acetate | 54 | $21,787 | $403 |
| Everolimus | 11 | $9,697 | $882 |
| Hydroxyurea | 13 | $694 | $53 |
| Anastrozole | 19 | $489 | $26 |
| Gabapentin | 21 | $452 | $22 |
| Prednisone | 32 | $351 | $11 |
| Levothyroxine | 12 | $257 | $21 |
| Lidocaine Hcl Viscous | 22 | $239 | $11 |
| Hydrocodone-Acetaminophen | 18 | $195 | $11 |
| Prochlorperazine Maleate | 14 | $173 | $12 |
| Oxycodone | 13 | $125 | $10 |
2022: 15 drugs
| Tagrisso | 106 | $1,790,005 | $16,887 |
| Mekinist | 23 | $312,007 | $13,566 |
| Tafinlar | 23 | $287,632 | $12,506 |
| Xalkori | 19 | $277,624 | $14,612 |
| Lynparza | 20 | $238,167 | $11,908 |
| Everolimus | 18 | $22,713 | $1,262 |
| Abiraterone Acetate | 40 | $11,907 | $298 |
| Xarelto | 15 | $8,778 | $585 |
| Hydroxyurea | 12 | $760 | $63 |
| Anastrozole | 25 | $609 | $24 |
| Gabapentin | 20 | $434 | $22 |
| Prednisone | 32 | $414 | $13 |
| Prochlorperazine Maleate | 21 | $360 | $17 |
| Hydrocodone-Acetaminophen | 11 | $355 | $32 |
| Ondansetron | 12 | $131 | $11 |
2021: 18 drugs
| Tagrisso | 87 | $1,430,989 | $16,448 |
| Xalkori | 22 | $353,055 | $16,048 |
| Mekinist | 31 | $345,561 | $11,147 |
| Ibrance | 27 | $339,248 | $12,565 |
| Lorbrena | 12 | $308,919 | $25,743 |
| Tafinlar | 31 | $278,563 | $8,986 |
| Xtandi | 18 | $272,733 | $15,152 |
| Tabrecta | 12 | $212,864 | $17,739 |
| Iressa | 12 | $97,521 | $8,127 |
| Lynparza | 13 | $95,547 | $7,350 |
| Xarelto | 12 | $12,190 | $1,016 |
| Abiraterone Acetate | 44 | $8,157 | $185 |
| Hydrocodone-Acetaminophen | 31 | $985 | $32 |
| Anastrozole | 37 | $901 | $24 |
| Prednisone | 36 | $701 | $19 |
| Ondansetron | 15 | $205 | $14 |
| Nystatin | 14 | $175 | $12 |
| Lorazepam | 16 | $105 | $7 |
2020: 19 drugs
| Tagrisso | 53 | $839,189 | $15,834 |
| Ibrance | 44 | $559,975 | $12,727 |
| Xtandi | 38 | $385,459 | $10,144 |
| Xalkori | 15 | $280,028 | $18,669 |
| Lorbrena | 15 | $275,018 | $18,335 |
| Mekinist | 23 | $224,294 | $9,752 |
| Tafinlar | 22 | $153,608 | $6,982 |
| Lynparza | 13 | $102,523 | $7,886 |
| Iressa | 12 | $97,521 | $8,127 |
| Xarelto | 12 | $10,887 | $907 |
| Abiraterone Acetate | 28 | $7,929 | $283 |
| Anastrozole | 44 | $1,071 | $24 |
| Dexamethasone | 11 | $650 | $59 |
| Entecavir | 12 | $566 | $47 |
| Prednisone | 26 | $507 | $20 |
| Gabapentin | 11 | $314 | $29 |
| Letrozole | 13 | $291 | $22 |
| Bicalutamide | 14 | $187 | $13 |
| Ondansetron | 16 | $155 | $10 |
2019: 1 drug
| Ibrance | 11 | $142,347 | $12,941 |
Professional record
- NPI
- 1033360946
- Trained
- Chicago College of Osteopathy, 2008
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 8901 Wisconsin Ave, Gme Office, Bldg 10, Room 1006, Bethesda, MD, 20889
- NPI first listed
- 2008-10-09
- NPI last updated
- 2022-02-11
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.